| saruplase vs streptokinase | No demonstrated result | | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
|---|
| short term death | 0.85 [0.63 1.14] | p=1.00 | 0 | 3089 | 1 | COMPASS, | | reinfarction | no data | | Cardiovascular death | no data | | Long term death | 0.86 [0.67 1.10] | p=1.00 | 0 | 3089 | 1 | COMPASS, | | Haemmorhagic stroke | no data | | stroke (fatal and non fatal) | 1.00 [0.55 1.82] | p=1.00 | 0 | 3089 | 1 | COMPASS, | | Major bleeding | 0.84 [0.53 1.36] | p=1.00 | 0 | 3089 | 1 | COMPASS, |
TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |
| saruplase vs t-PA | No demonstrated result | | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
|---|
| short term death | 1.23 [0.50 3.02] | p=1.00 | 0 | 473 | 1 | SESAM, | | reinfarction | 1.00 [0.41 2.46] | p=1.00 | 0 | 473 | 1 | SESAM, | | Cardiovascular death | no data | | Long term death | no data | | Haemmorhagic stroke | 1.00 [0.14 7.19] | p=1.00 | 0 | 473 | 1 | SESAM, | | stroke (fatal and non fatal) | 0.80 [0.21 3.03] | p=1.00 | 0 | 473 | 1 | SESAM, | | Major bleeding | 1.10 [0.59 2.08] | p=1.00 | 0 | 473 | 1 | SESAM, |
TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |
| saruplase vs urokinase | No demonstrated result | | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
|---|
| short term death | no data | | reinfarction | no data | | Cardiovascular death | no data | | Long term death | no data | | Haemmorhagic stroke | no data | | stroke (fatal and non fatal) | no data | | Major bleeding | no data |
TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |
